deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02080403

The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis

Multi-Center Phase 3 Trial of Chlorhexidine Gluconate Chip for the Use in Subjects With Peri-Implantitis.

Sponsor: Dexcel Pharma Technologies Ltd.

Conditions Peri-Implantitis
Interventions 2.5 mg Chlorhexidine gluconate chip
Updated 11 times since 2017 Last updated: Aug 24, 2022 Started: Jul 31, 2014 Primary completion: Oct 31, 2018 Completion: Nov 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02080403, this PHASE3 trial focuses on Peri-Implantitis and remains completed. Sponsored by Dexcel Pharma Technologies Ltd., it has been updated 11 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotRecruiting~Jul 2017 – ~Mar 2018 · 8 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotActive Not Recruiting~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotCompleted~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotCompleted~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshotCompleted~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE3

  4. Sep 2021 — Sep 2022 [monthly]

    Completed PHASE3

  5. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE3

▶ Show 6 earlier versions

  1. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  2. Jun 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE3

  3. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  4. Jul 2017 — Mar 2018 [monthly]

    Recruiting PHASE3

  5. Feb 2017 — Jul 2017 [monthly]

    Recruiting PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dexcel Pharma Technologies Ltd.
Data source: Dexcel Pharma Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations